Simmons Bank Merck & Co., Inc. Transaction History

Simmons Bank

$1.37 Billion
Q3 2024

A detailed history of Simmons Bank transactions in Merck & Co., Inc. stock. As of the latest transaction made, Simmons Bank holds 84,911 shares of MRK stock, worth $8.33 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares

84,911

Previous 86,737 2.11%

Holding current value

$8.33 Million

Previous $10.7 Million 10.21%

% of portfolio

0.71%

Previous 0.82%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$111.15 - $128.97 $202,959 - $235,499	-1,826 Reduced 2.11%	84,911 $9.64 Million
Q2 2024 Jul 26, 2024	SELL	$123.8 - $132.96 $257,380 - $276,423	-2,079 Reduced 2.34%	86,737 $10.7 Million
Q1 2024 May 14, 2024	SELL	$113.24 - $131.95 $108,710 - $126,671	-960 Reduced 1.07%	88,816 $11.7 Million
Q4 2023 Feb 06, 2024	SELL	$100.18 - $109.02 $103,586 - $112,726	-1,034 Reduced 1.14%	89,776 $9.79 Million
Q3 2023 Oct 26, 2023	SELL	$102.95 - $114.33 $16,266 - $18,064	-158 Reduced 0.17%	90,810 $9.35 Million
Q2 2023 Aug 03, 2023	SELL	$108.61 - $118.38 $178,663 - $194,735	-1,645 Reduced 1.78%	90,968 $10.5 Million
Q1 2023 Apr 28, 2023	BUY	$102.94 - $114.86 $253,952 - $283,359	2,467 Added 2.74%	92,613 $9.85 Million
Q4 2022 Feb 08, 2023	SELL	$87.44 - $112.11 $5,683 - $7,287	-65 Reduced 0.07%	90,146 $10 Million
Q3 2022 Oct 27, 2022	SELL	$84.53 - $94.96 $91,038 - $102,271	-1,077 Reduced 1.18%	90,211 $7.77 Million
Q2 2022 Jul 29, 2022	SELL	$83.49 - $94.64 $1.85 Million - $2.1 Million	-22,193 Reduced 19.56%	91,288 $8.32 Million
Q1 2022 Apr 21, 2022	SELL	$73.51 - $82.4 $143,638 - $161,009	-1,954 Reduced 1.69%	113,481 $9.31 Million
Q4 2021 Jan 28, 2022	SELL	$72.28 - $90.54 $138,633 - $173,655	-1,918 Reduced 1.63%	115,435 $8.85 Million
Q3 2021 Oct 26, 2021	SELL	$71.68 - $78.83 $724,398 - $796,655	-10,106 Reduced 7.93%	117,353 $8.82 Million
Q2 2021 Aug 05, 2021	SELL	$70.31 - $77.77 $529,926 - $586,152	-7,537 Reduced 5.58%	127,459 $9.91 Million
Q1 2021 May 06, 2021	SELL	$68.86 - $81.11 $544,200 - $641,012	-7,903 Reduced 5.53%	134,996 $10.4 Million
Q4 2020 Feb 08, 2021	SELL	$71.77 - $79.65 $544,734 - $604,543	-7,590 Reduced 5.04%	142,899 $11.7 Million
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $220,271 - $249,679	-3,010 Reduced 1.96%	150,489 $12.5 Million
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $218,372 - $248,483	3,101 Added 2.06%	153,499 $11.9 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $878,866 - $1.22 Million	13,871 Added 10.16%	150,398 $11.6 Million
Q4 2019 Jan 31, 2020	SELL	$77.58 - $87.54 $112,025 - $126,407	-1,444 Reduced 1.05%	136,527 $12.4 Million
Q3 2019 Nov 13, 2019	BUY	$76.08 - $82.93 $264,986 - $288,845	3,483 Added 2.59%	137,971 $11.6 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $293,467 - $342,841	-4,202 Reduced 3.03%	134,488 $11.3 Million
Q1 2019 May 13, 2019	BUY	$69.58 - $79.36 $51,280 - $58,488	737 Added 0.53%	138,690 $11.5 Million
Q4 2018 Jan 24, 2019	BUY	$65.24 - $75.71 $235,516 - $273,313	3,610 Added 2.69%	137,953 $10.5 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $8,538 - $10,040	-148 Reduced 0.11%	134,343 $9.53 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $206,268 - $242,343	4,058 Added 3.11%	134,491 $8.16 Million
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $909,788 - $1.06 Million	17,853 Added 15.86%	130,433 $7.1 Million
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $424,006 - $506,310	-8,214 Reduced 6.8%	112,580 $6.33 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $56,968 - $61,299	971 Added 0.81%	120,794 $7.74 Million
Q2 2017 Aug 15, 2017	BUY	N/A	119,823	119,823 $7.68 Million

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simmons Bank, based on Form 13F filings with the SEC.

News

Stay updated on Simmons Bank with notifications on news.

Account